Enlivex Therapeutics Ltd Live Stock Price Today, Share Analysis and Chart

Name: Enlivex Therapeutics Ltd: Is Infosys Ltd. worth buying?
Item: Enlivex Therapeutics Ltd
Rating: 1.36816675
Author: Trendlyne DVM scores

about

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy t...

1.06 -0.01 (-0.93%)

49.52% Fall from 52W High

185.6K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.7 / 100

Technically Neutral

43.1 / 100

No estimates available

Enlivex Therapeutics Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Enlivex Therapeutics Ltd Live Stock Price Today, Share Analysis and Chart

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy t...

49.52% Fall from 52W High

SWOT Analysis

Enlivex Therapeutics Live Price Chart